Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 61 AL 75

Advances in Alzheimer's disease drug development

Rafii MS, Aisen PS.

BMC Med. 2015 Mar 25;13:62. doi: 10.1186/s12916-015-0297-4.

New developments of clinical trial in immunotherapy for Alzheimer's disease

Yang C, Xiao S.

Curr Pharm Biotechnol. 2015;16(6):484-91. doi: 10.2174/138920101606150407112319.

Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials

Jiang J, Jiang H.

Neurol Sci. 2015 Sep;36(9):1633-41. doi: 10.1007/s10072-015-2221-2. Epub 2015 Apr 22.

Memantine extended release (28 mg once daily): a review of its use in Alzheimer's disease

Plosker GL.

Drugs. 2015 May;75(8):887-97. doi: 10.1007/s40265-015-0400-3.

Rodent models for Alzheimer's disease drug discovery

Puzzo D, Gulisano W, Palmeri A, Arancio O.

Expert Opin Drug Discov. 2015 Jul;10(7):703-11. doi: 10.1517/17460441.2015.1041913. Epub 2015 Apr 30.

Nanomedicine for the treatment of Alzheimer's disease

Gregori M, Masserini M, Mancini S.

Nanomedicine (Lond). 2015;10(7):1203-18. doi: 10.2217/nnm.14.206.

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial

Butchart J, Brook L, Hopkins V, Teeling J, Püntener U, Culliford D, Sharples R, Sharif S, McFarlane B, Raybould R, Thomas R, Passmore P, Perry VH, Holmes C.

Neurology. 2015 May 26;84(21):2161-8. doi: 10.1212/WNL.0000000000001617. Epub 2015 May 1.

Masitinib for the treatment of mild to moderate Alzheimer's disease

Folch J, Petrov D, Ettcheto M, Pedrós I, Abad S, Beas-Zarate C, Lazarowski A, Marin M, Olloquequi J, Auladell C, Camins A.

Expert Rev Neurother. 2015 Jun;15(6):587-96. doi: 10.1586/14737175.2015.1045419. Epub 2015 May 11.

Drug repositioning in Alzheimer's disease

Corbett A, Williams G, Ballard C.

Front Biosci (Schol Ed). 2015 Jun 1;7(1):184-8. doi: 10.2741/S432.

Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer's Disease

Faldu KG, Shah JS, Patel SS.

Recent Pat Antiinfect Drug Discov. 2015;10(2):76-83. doi: 10.2174/1574891x10666150509193236.

Therapeutic Effects of Herbal Chemicals in Traditional Chinese Medicine on Alzheimer's Disease

Cheung TS, Song TH, Ng TB, Wu FH, Lao LX, Tang SC, Ho JC, Zhang KY, Sze SC.

Curr Med Chem. 2015;22(19):2392-403. doi: 10.2174/0929867322666150520095509.

A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers

Boinpally R, Chen L, Zukin SR, McClure N, Hofbauer RK, Periclou A.

Clin Drug Investig. 2015 Jul;35(7):427-35. doi: 10.1007/s40261-015-0296-4.

Editorial: Small molecule therapeutics for Alzheimer's disease

Ma DL, Leung CH.

Curr Alzheimer Res. 2015;12(5):400-2. doi: 10.2174/156720501205150526115737.

Statins for Treating Alzheimer's Disease: Truly Ineffective?

Liang T, Li R, Cheng O.

Eur Neurol. 2015;73(5-6):360-6. doi: 10.1159/000382128. Epub 2015 May 28.

Idalopirdine as a treatment for Alzheimer's disease

Galimberti D, Scarpini E.

Expert Opin Investig Drugs. 2015;24(7):981-7. doi: 10.1517/13543784.2015.1052402. Epub 2015 May 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias